Legend Biotech (LEGN) Equity Ratio (2019 - 2025)

Legend Biotech has reported Equity Ratio for 7 years, with the latest figure at 0.58 in Q4 2025.

• For the quarter ending Q4 2025, Equity Ratio fell 7.23% year-over-year to 0.58; the trailing twelve-month figure through Dec 2025 stood at 0.58 (down 7.23% YoY), and the FY2025 full-year result was 0.58, down 7.23% from the prior year.
• Equity Ratio for Q4 2025 stood at 0.58, down from 0.59 in the prior quarter.
• The five-year high for Equity Ratio was 0.73 in Q2 2023, with the low at 0.0 in Q1 2021.
• Historically, Equity Ratio has averaged 0.55 across 5 years, with a median of 0.63 in 2024.
• Annual changes were most pronounced in 2022 — Equity Ratio soared 211531788.55% — and 2023, when it slipped 23.91%.
• Legend Biotech's Equity Ratio stood at 0.68 in 2021, then declined by 18.27% to 0.56 in 2022, then rose by 21.05% to 0.68 in 2023, then slipped by 7.96% to 0.62 in 2024, then fell by 7.23% to 0.58 in 2025.
• The last three Equity Ratio figures came in at 0.58 (Q4 2025), 0.59 (Q3 2025), and 0.61 (Q2 2025), per Business Quant data.